Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer.
Abu Shadat M NomanRashed R ParagMuhammad I RashidMohammad Z RahmanAli A ChowdhuryAfrin SultanaChandsultana JerinAyesha SiddiquaLutfur RahmanAfsana ShirinJunayed NayeemReaz MahmudSonam AktherRajib K ShilIkram HossainSharmin AlamArfina ChowdhuryShabnam B BasherAbul HasanShammy BithyJannatul AklimaMizanur RahmanNabila ChowdhuryTahmina BanuBedri KarakasHerman YegerWalid A FarhatSyed S IslamPublished in: Therapeutic advances in medical oncology (2020)
These findings suggest that Shh and Nrf2 could serve as therapeutic targets as well as promising dual prognostic therapeutic biomarkers for HNSCC.